Longwood Fund

Longwood Fund was founded in 2010 by Christoph Westphal, Michelle Dipp and Richard Aldrich. Longwood Fund Management, LLC operates as a venture capital firm. The company invests in healthcare and life science sectors with a focus on biotechnology and therapeutics. Longwood Fund Management serves its clients in the United States.​

​

Longwood's mission is to identify technologies and fund companies that make a difference in the lives of patients, and also create significant value for investors. Longwood's stated goal is to launch and building healthcare companies and provide operational leadership and strategic guidance. ​

​

Founders

​Christoph Westphal MD, PhD, has served as co-founder, CEO, and lead investor of six companies (including Alnylam, Acceleron, Sirtris, and Momenta) that have completed IPOs, yielding an aggregate, sustained, value of $16 billion. Rich Aldrich was a co-founder of Vertex Pharmaceuticals, which currently has a market capitalisation of $60 billion.​

​

Investments

Longwood Founders Fund invests during early stage and late stage venture as well as dealing with Private Equity. Longwood Founders Fund has raised a total of $85 million across 4 funds, their latest being Longwood Fund V. Investments include Recros Medica, Bicycle Therapeutics and Channel Medsystems with exits including Flex Pharma, Verastem Oncology and PTC Therapeutics.​

​